SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 2,414.90 |
| Enterprise Value ($M) | n/a |
| Book Value ($M) | 213,470.00 |
| Book Value / Share | 2,871.58 |
| Price / Book | n/a |
| NCAV ($M) | 92,570.00 |
| NCAV / Share | 1,245.24 |
| Price / NCAV | n/a |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | 0.05 |
| Return on Assets (ROA) | 0.04 |
| Return on Equity (ROE) | 0.05 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 2.59 |
| Current Ratio | 3.11 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 144,468.00 |
| Assets | 265,368.00 |
| Liabilities | 51,898.00 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 165,600.00 |
| Operating Income | 24,710.00 |
| Net Income | 10,067.00 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 11,246.00 |
| Cash from Investing | -18,415.00 |
| Cash from Financing | -7,768.00 |
(click for more detail) |
|
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| Similar Companies | |
|---|---|
| IVEVF – Inventiva S.A. | KANT – Kineta, Inc. |
| KAYS – Kaya Holdings, Inc. | KLDO – Kaleido Biosciences, Inc. |
| KRBP – Kiromic BioPharma, Inc. |
Financial data and stock pages provided by
Fintel.io